Products & Services
• Therapeutics
• Diagnostics
• Crohn's Prognostic
• IBS Diagnostic
• IBD Serology
• Celiac
• Thiopurine Monitoring
• TPMT Testing
• Liver Fibrosis
• Serum Infliximab/HACA
• Lactose Intolerance
• NOD2/CARD15
• H. pylori
• Oncology

Visit www.IBSBloodTest.com for detailed information.

PROMETHEUS^® IBS Diagnostic is the first blood-based biomarker test for Irritable Bowel Syndrome (IBS). Utilizing proprietary and patented markers and incorporating sophisticated pattern recognition technology PROMETHEUS IBS Diagnostic can aid clinicians in the diagnosis of IBS. PROMETHEUS IBS Diagnostic was validated using well-characterized IBS samples collected from recognized IBS experts and GI clinics. The samples were either Rome II or Rome III positive and the patients had a diagnosis of IBS for greater than one year.

PROMETHEUS^® IBS Diagnostic manuscript is now published in Alimentary Pharmacology & Therapeutics. To view the abstract and/or purchase the manuscript please go to
http://www3.interscience.wiley.com/journal/122208589/abstract

Resources

IBS Diagnostic Product Detail Sample insurance correspondence for PROMETHEUS® IBS Diagnostic Prior Authorization Request Letter of Appeal Letter of Medical Necessity

Prometheus diagnostic services provide important information to aid in the diagnosis and management of certain diseases and conditions. How this information is used to guide patient care is the responsibility of the physician.